Sarah Rosen | Senior Director, Non-Interventional Studies
Evidera part of the PPD clinical research business of Thermo Fisher Scientific
Sarah Rosen, MSc, is a Senior Director within the RWE group at Evidera, part of the PPD clinical research business of Thermo Fisher Scientific, in France. Ms. Rosen has been working in non-interventional studies for nearly 20 years, initially as a Project Manager and Oversight Director, and now works in the strategic delivery team within the Non-Interventional Studies department focusing on safety and vaccines. Ms. Rosen has global experience focused on primary data collection studies including post-authorization safety studies, disease and drug registries, natural history studies, and also quality of life studies, and effectiveness studies.
Appearances:
Day 2 - Wednesday 30th October @ 13:00
Unlocking the Power of Real-World Data (RWD) and Real-World Evidence (RWE) in Vaccine Development: A Comprehensive Approach to RWE Across the Lifecycle
Regulators and payors are increasingly integrating real-world evidence (RWE) of safety, effectiveness, and value to inform their decision-making. Discover how RWE, generated using real-world data (RWD), can provide valuable insights from early in development and throughout the vaccine lifecycle. Join us as we:- Explore the diverse types of RWE that can effectively support vaccine development
- Provide insights into planning for the collection of RWD throughout vaccine development
- Discuss opportunities to leverage RWD within clinical trials
- Share examples of uses of RWE from early stage through post-marketing
Identifying challenges and opportunities in planning for RWE generation during vaccine development
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events